AZD-5658

N/A

Report date: 2025/04/08 14:04:53
NME

Base Information

Drug NameAZD-5658
Drug Alias NameAZD-5658
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 2Lupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesAstrazeneca Plc
Active IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A